(Non-)ST-elevation myocardial infarction and Multivessel coronary Artery disease: coronary Resistance guided multivessel Treatment. - SMART

Academisch Medisch Centrum0 个研究点目标入组 300 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Patients with a second and/or third coronary lesion in the presence of a successfully treated acute coronary occlusion of another coronary vessel are amendable for inclusion.

•- Age under 18 and above 80 yrs.
•- Cardiogenic shock
•- Anatomical or anticipated problems for complete percutaneous coronary revascularization i.e. diffuse disease, chronic total occlusion.
•- Prior or indication for coronary artery bypass grafting (CABG)
•- Presence of a significant left main coronary artery stenosis (> 50% diameter stenosis)
•- Renal impairment (e.g. serum creatinine level of more than 130 *mol/L)
•-Unable to exercise
•-Ventricular arrhythmias, i.e. sustained ventricular tachycardia (VT) or ventricular fibrillation (VF), more than 48 hours after primary PCI
•-Severe valvular heart disease requiring cardiac surgery within twelve months
•-Serious known concomitant disease with a life expectancy of less than one year
•-Factors making follow-up difficult (e.g. not fixed home or address, psychological instability, drugs or alcohol addiction, etc.).
•-Current participation in another trial.

发起方